Akso Health Group ADR (AHG)vsCencora Inc. (COR)
AHG
Akso Health Group ADR
$2.36
-2.48%
HEALTHCARE · Cap: $807.33M
COR
Cencora Inc.
$326.91
-1.46%
HEALTHCARE · Cap: $65.11B
Smart Verdict
WallStSmart Research — data-driven comparison
Cencora Inc. generates 2204408% more annual revenue ($325.78B vs $14.78M). COR leads profitability with a 50.0% profit margin vs 0.0%. COR earns a higher WallStSmart Score of 62/100 (C+).
AHG
Avoid24
out of 100
Grade: F
COR
Buy62
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for AHG.
Margin of Safety
-44.0%
Fair Value
$253.90
Current Price
$326.91
$73.01 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 415.8% year-over-year
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Every $100 of equity generates 134 in profit
Keeps 50 of every $100 in revenue as profit
Strong operational efficiency at 118.0%
Large-cap with strong market position
Growing faster than its price suggests
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Premium valuation, high expectations priced in
Trading at 33.3x book value
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : AHG
The strongest argument for AHG centers on Revenue Growth, Debt/Equity, Altman Z-Score. Revenue growth of 415.8% demonstrates continued momentum.
Bull Case : COR
The strongest argument for COR centers on Return on Equity, Profit Margin, Operating Margin. Profitability is solid with margins at 50.0% and operating margin at 118.0%. PEG of 0.82 suggests the stock is reasonably priced for its growth.
Bear Case : AHG
The primary concerns for AHG are EPS Growth, Market Cap, Profit Margin.
Bear Case : COR
The primary concerns for COR are P/E Ratio, Price/Book, Free Cash Flow. A P/E of 40.2x leaves little room for execution misses.
Key Dynamics to Monitor
AHG profiles as a hypergrowth stock while COR is a mature play — different risk/reward profiles.
COR carries more volatility with a beta of 0.65 — expect wider price swings.
AHG is growing revenue faster at 415.8% — sustainability is the question.
AHG generates stronger free cash flow (3M), providing more financial flexibility.
Bottom Line
COR scores higher overall (62/100 vs 24/100), backed by strong 50.0% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Akso Health Group ADR
HEALTHCARE · MEDICAL DISTRIBUTION · China
Akso Health Group ADR is a leading entity in the healthcare sector, focused on delivering innovative medical solutions and integrated patient care services. With a specialization in advanced health technologies, the company is well-positioned to tap into growth opportunities in telehealth and personalized medicine, bolstered by a strong commitment to research and development. Its robust business model and dedication to quality, supported by a skilled team of professionals, make Akso Health Group an appealing investment for institutional investors aiming to navigate the transformative landscape of healthcare.
Visit Website →Cencora Inc.
HEALTHCARE · MEDICAL DISTRIBUTION · USA
CoreSite Realty Corporation (NYSE: COR) delivers secure, reliable, high-performance data center, cloud access and interconnect solutions to a growing client ecosystem in eight key North American markets.
Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?